# US 2025/0084458 A1 · Capture construct and method for detecting a plurality of analytes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0084458 A1
- Document ID: US20250084458A1
- Status: Published application
- Kind: A1
- Application number: 18/284,550
- Filed: 2022-03-31
- Published: 2025-03-13
- Earliest claimed: 2021-04-01
- Assignees: Leica Microsystems CMS GmbH
- Applicants: Leica Microsystems Cms GmbH
- Inventors: Soeren ALSHEIMER; Arnold GISKE
- Web page: https://patentgrep.com/patent/US20250084458A1

## CPC

- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- G06T 7/0014: {using an image reference approach}
- C12Q 1/6818: involving interaction of two or more labels, e.g. resonant energy transfer
- C12Q 1/6825: Nucleic acid detection involving sensors
- G01N 33/5094: {for blood cell populations (red blood cells G01N33/80)}
- G01N 33/542: with steric inhibition or signal modification, e.g. fluorescent quenching
- G02B 21/365: {Control or image processing arrangements for digital or video microscopes (G02B21/361, G02B21/362 take precedence)}
- H04N 13/207: using a single two-dimensional [2D] image sensor
- G01N 2458/10: Oligonucleotides as tagging agents for labelling antibodies
- G06T 2200/04: involving 3D image data
- G06T 2207/10056: Microscopic image
- G06T 2207/30024: Cell structures in vitro; Tissue sections in vitro
- G06T 2207/30096: Tumor; Lesion
- G06T 2207/30204: Marker
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G06T: IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G02B: OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- H04N: PICTORIAL COMMUNICATION, e.g. TELEVISION

## Abstract

A capture construct for capturing a plurality of analytes of a biological sample includes a nanostructure backbone, at least a first orientation indicator and a second orientation indicator, and at least a first plurality of capture regions on the nanostructure backbone. Each capture region includes at least one affinity capture reagent configured to capture one of the plurality of analytes.

## Claims

### Claim 1

A capture construct for capturing a plurality of analytes of a biological sample, the capture construct comprising:
a nanostructure backbone,
at least a first orientation indicator and a second orientation indicator, and
at least a first plurality of capture regions on the nanostructure backbone, each capture region comprising at least one affinity capture reagent, configured to capture one of the plurality of analytes.

### Claim 2 (depends on 1)

The capture construct according to claim 1, wherein the nanostructure backbone comprises nucleic acids.

### Claim 3 (depends on 1)

The capture construct according to claim 1, wherein the at least one affinity capture reagent comprises an antibody, an antibody fragment, an oligonucleotide, an aptamer, a peptide, a drug, and/or a toxin, or a combination thereof.

### Claim 4 (depends on 1)

The capture construct according to claim 1, further comprising a first plurality of affinity reporter reagents, each affinity reporter reagent comprising a first reporter tag and configured to attach to a respective analyte of the plurality of analytes, wherein the first reporter tag is readable, to determine whether or not the respective analyte is captured by the at least one affinity capture reagent.

### Claim 5 (depends on 4)

The capture construct according to claim 4, wherein each affinity reporter reagent comprises an antibody, an antibody fragment, an oligonucleotide, an aptamer, a peptide, a drug, and/or a toxin, or a combination thereof.

### Claim 6 (depends on 4)

The capture construct according to claim 4, wherein the first reporter tag is optically readable.

### Claim 7 (depends on 4)

The capture construct according to claim 4, wherein the first reporter tag comprises an oligonucleotide and is readable by sequencing.

### Claim 8 (depends on 1)

The capture construct according to claim 1, wherein the at least one affinity capture reagent is bound to the nanostructure backbone, or
wherein the at least one affinity capture reagent of a particular capture region of the first plurality of capture regions comprises an oligonucleotide, and the particular capture region comprises a complementary oligonucleotide to bind to the oligonucleotide of the at least one affinity capture reagent.

### Claim 9 (depends on 1)

The capture construct according claim 1, wherein the nanostructure backbone comprises at least a second plurality of capture regions, each capture region of the second plurality of capture regions comprising at least one affinity capture reagent configured to capture one of the plurality of analytes.

### Claim 10 (depends on 9)

The capture construct according to claim 9, further comprising a second plurality of affinity reporter reagents, each affinity reporter reagent of the second plurality of affinity reporter reagents comprising a second reporter tag and configured to attach to a respective analyte of the plurality of analytes, wherein the second reporter tag is readable, to determine whether or not the respective analyte is captured by the respective affinity capture reagent.

### Claim 11 (depends on 1)

The capture construct according to claim 1, wherein the nanostructure backbone extends linearly in one dimension, and the first orientation indicator and the second orientation indicator are spaced apart from each other, or arranged on opposite ends of the nanostructure backbone.

### Claim 12 (depends on 1)

The capture construct according to claim 1, wherein the nanostructure backbone extends in two dimensions or three dimensions, and the nanostructure backbone comprises at least a third orientation indicator.

### Claim 13 (depends on 1)

The capture construct according to claim 1, wherein a largest spatial extent of the nanostructure backbone is in a range from 1 nm to 10000 nm.

### Claim 14 (depends on 1)

The capture construct according to claim 1, wherein the capture regions of the first plurality of capture regions are spaced apart from each other in a range from 1 nm to 2000 nm.

### Claim 15 (depends on 9)

The capture construct according to claim 9, wherein the capture regions of the first plurality of capture regions are spaced apart from the capture regions of the second plurality of capture regions in a range from 0.1 nm to 500 nm.

### Claim 16 (depends on 4)

The capture construct according to claim 4, wherein the first reporter tags comprise fluorophores, in particular with differing excitation wavelengths, differing fluorescence emission wavelengths, and/or differing fluorescence lifetime characteristics.

### Claim 17 (depends on 1)

The capture construct according to claim 1, wherein the affinity capture reagent of at least one of the first plurality of capture regions is configured to bind a respective analyte of the plurality of analytes at a single binding site of the respective analyte.

### Claim 18 (depends on 1)

The capture construct according to claim 1, wherein at least one capture region of the first plurality of capture regions comprises a first set of affinity capture reagents and a second set of affinity capture reagents, and wherein the first set of affinity capture reagents is configured to bind one analyte of the plurality of analytes at a first binding site of the one analyte and the second set of affinity capture reagents is configured to bind the one analyte of the plurality of analytes at a second binding site of the one analyte.

### Claim 19 (depends on 18)

The capture construct according to claim 18, wherein the first set of affinity capture reagents comprises first capture reagent dyes, and the second set of affinity capture reagents comprises second capture reagent dyes, wherein the first capture reagent dyes and the second capture reagent dyes are fluorophores.

### Claim 20 (depends on 19)

The capture construct according to claim 19, wherein the first capture reagent dyes and the second capture reagent dyes are configured to be brought into a proximity when the one analyte is captured by one of the affinity capture reagents of the first set of affinity capture reagents and by one of the affinity capture reagents of the second set of affinity capture reagents, and wherein the proximity enables an energy transfer between the first capture reagent dyes and the second capture reagent dyes.

### Claim 21 (depends on 1)

The capture construct according to claim 1, wherein the capture construct and the biological sample are embedded in or attached to a polymeric compound.

### Claim 22 (depends on 1)

A method for detecting a plurality of analytes of a biological sample, the method comprising the following steps:
incubation of the biological sample in a presence of at least one capture construct according to claim 1,
acquiring a read-out of at least the one capture construct, and
determining whether or not a respective analyte is captured by the respective affinity capture reagent.
